The other 10 patients harboured CALR mutations, classified in type 1 (del52, n = 6) and type 2 (ins5, n = 4) mutations.9 The diagnosis of each MPN subtype was established according to the World Health Organization (WHO) 2016 criteria.10 Here, CALR is linked to myeloproliferative disorder.